Chronic Lymphocytic Leukemia | Specialty

The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy.

Goals of Therapy in CLL

August 29th 2017

CLL: The Biologics of Ibrutinib Therapy

August 23rd 2017

Treatment for Cytogenetic-related Outcomes in CLL

August 23rd 2017

Patient Selection for CLL Treatment

August 23rd 2017

CLL: Factors for Upfront Therapy

August 23rd 2017

Risk Stratification in CLL

August 23rd 2017

Dr. Nastoupil on Questions Surrounding TGR1202 in Patients With CLL

August 21st 2017

Loretta J. Nastoupil, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the questions researchers are currently facing with TGR1202 in patients with chronic lymphocytic leukemia (CLL).

Dr. Byrd on Long-term Safety Data With Ibrutinib in CLL

August 17th 2017

John C. Byrd, MD, D. Warren Brown Chair of Leukemia Research, professor of medicine, Medicinal Chemistry and Veterinary Biosciences, director, Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, discusses long-term safety data with ibrutinib (Imbruvica) as treatment for patients with chronic lymphocytic leukemia (CLL).

Dr. Chavez Shares His Advice for Treating Patients With CLL

August 16th 2017

Julio Chavez, MD, of the Department of Malignant Hematology at Moffitt Cancer Center, shares his advice for oncologists treating patients with chronic lymphocytic leukemia.

The Future of Treatment in Follicular Lymphoma

August 15th 2017

Novel Therapies in FL: Benefits and Challenges

August 15th 2017

Combination Therapy's Role in Follicular Lymphoma

August 15th 2017

Impact of Copanlisib in Follicular Lymphoma

August 15th 2017

Considering the Value of PI3 Kinase Inhibitors in FL

August 15th 2017

Addressing Unmet Needs in Salvage Therapy for FL

August 15th 2017

The Evolving Landscape of Salvage Therapy for FL

August 15th 2017

Choosing Therapy for Relapsed/Refractory FL

August 15th 2017

Continuing FL Treatment: Maintenance and Surveillance

August 15th 2017

Systemic Treatment for Newly Diagnosed FL

August 15th 2017

Triggers to Initiate Therapy for Follicular Lymphoma

August 15th 2017